{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"HeartBeam Reports Third Quarter 2026 Results - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"JQzoEgOJa1\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/heartbeam-reports-third-quarter-2026-results\/\">HeartBeam Reports Third Quarter 2026 Results<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/heartbeam-reports-third-quarter-2026-results\/embed\/#?secret=JQzoEgOJa1\" width=\"600\" height=\"338\" title=\"&#8220;HeartBeam Reports Third Quarter 2026 Results&#8221; &#8212; Market Newsdesk\" data-secret=\"JQzoEgOJa1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"HeartBeam Reports Third Quarter 2026 Results Redirected the Majority of Company Resources to Heart Attack Assessment, a Market Opportunity 4x Larger than the Arrhythmia Market Received FDA Breakthrough Device Designation for Heart Attack Assessment and Accepted into FDA&#8217;s Total Product Life Cycle Advisory Program (TAP) Reported Positive ALIGN-ACS Pilot Study Results at TCT 2026 with HeartBeam Patient-Recorded ECG Demonstrating Higher Specificity Than Standard 12-Lead ECG for Heart Attack Assessment U.S. Pivotal Study for Heart Attack Assessment Planned to Begin in First Quarter of 2027 Created Capital Efficiency with Focused Path to Heart Attack Assessment, Resulting in a 23% Reduction in Quarterly Operating Cash Outflows Management to Host Webcast and Conference Call Today at 4:30 p.m. ET SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;HeartBeam, &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261112561877r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"}